bluebird bio's Zynteglo has become the first cell-based gene therapy to be approved in the US, getting the nod from the FDA as a treatment for patients with beta thalassaemia who require regular blood ...
US cost-effectiveness watchdog ICER has handed bluebird bio some good news ahead of its FDA advisory committee meeting for rare blood disorder gene therapy beti-cel in June, by endorsing its proposed ...
At MP3Juices, we have everything you need to get your music fixed in one place. With a wide selection of tracks from popular artists and bands, we're sure you'll find what you're looking for. Explore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results